Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

3-ingenyl angelate 39Imiquimod 22Aminolevulinic Acid 22Photochemotherapy 16methyl 5-aminolevulinate 12Fluorouracil 11Diclofenac 11Gels 10Cryotherapy 6Solutions 5BF-200 ALA 5tirbanibulin 4Radiotherapy 4Prilocaine 4Lidocaine 4LEO 43204 4Petrolatum 3Ointments 3Cryosurgery 3calcipotriene 2SR-T100 2Niacinamide 2Blue Light 21-phenyl-3,3-dimethyltriazene 2tazarotene 1potassium dobesilate 1perillyl alcohol 1endonuclease V, phage T4 1dexpanthenol 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Keratosis, Actinic × Deoxyribonuclease (Pyrimidine Dimer) × Clear all
NCT00089180 2015-12-04

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

National Cancer Institute (NCI)

Phase 2 Completed
100 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡